| Autor: |
M Belhouari, S Khalfi, C Khalfi, N Benchakroune, M Bourhafour, T Chekrine, Z Bouchbika, N Tawfik, H Jouhadi, Z Alami, T Bouhafa, A Benider, S Sahraoui |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
World Journal of Advanced Research and Reviews. 17:598-601 |
| ISSN: |
2581-9615 |
| Popis: |
Lung cancer is a public health problem in the world, en 2020: 2nd most common cancer after breast cancer. Smoking is the main risk factor constituting an essential axis of prevention. Non-small cell lung cancer is the most common histological component representing approximately 85%, currently 75% of patients have unfortunately become at advanced stages, the prognosis remains poor: incidence and expectation are close, but metastatic NSCLC has experienced a total renewal of the therapeutic arsenal. It is a model of precision medicine and also in particular a model for immunotherapy. We are recently faced with an expanded therapeutic arsenal posing a problem of choice. with a durable complete response with Atezolizumab. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
